State Street’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $418K | Buy |
1,694,783
+339,200
| +25% | +$135K | ﹤0.01% | 3704 |
|
|
2025
Q4 | $569K | Hold |
1,355,583
| – | – | ﹤0.01% | 3646 |
|
|
2025
Q3 | $913K | Buy |
1,355,583
+519,131
| +62% | +$280K | ﹤0.01% | 3531 |
|
|
2025
Q2 | $453K | Sell |
836,452
-286,492
| -26% | -$170K | ﹤0.01% | 3634 |
|
|
2025
Q1 | $736K | Sell |
1,122,944
-3,896,091
| -78% | -$4.13M | ﹤0.01% | 3498 |
|
|
2024
Q4 | $5.12M | Buy |
5,019,035
+4,354,414
| +655% | +$7.96M | ﹤0.01% | 2965 |
|
|
2024
Q3 | $576K | Buy |
664,621
+145,400
| +28% | +$107K | ﹤0.01% | 3572 |
|
|
2024
Q2 | $186K | Sell |
519,221
-2,232,583
| -81% | -$1.21M | ﹤0.01% | 3844 |
|
|
2024
Q1 | $1.84M | Buy |
2,751,804
+43,436
| +2% | +$31.5K | ﹤0.01% | 3303 |
|
|
2023
Q4 | $1.47M | Buy |
2,708,368
+22,283
| +0.8% | +$10.3K | ﹤0.01% | 3394 |
|
|
2023
Q3 | $1.61M | Buy |
2,686,085
+30,458
| +1% | +$32.6K | ﹤0.01% | 3411 |
|
|
2023
Q2 | $3.45M | Sell |
2,655,627
-6,304,951
| -70% | -$8.61M | ﹤0.01% | 3173 |
|
|
2023
Q1 | $15.8M | Sell |
8,960,578
-828,306
| -8% | -$2.36M | ﹤0.01% | 2384 |
|
|
2022
Q4 | $30.7M | Buy |
9,788,884
+2,820,608
| +40% | +$10.9M | ﹤0.01% | 1945 |
|
|
2022
Q3 | $34.1M | Sell |
6,968,276
-771,195
| -10% | -$3.96M | ﹤0.01% | 1867 |
|
|
2022
Q2 | $32M | Sell |
7,739,471
-35,856
| -0.5% | -$155K | ﹤0.01% | 1924 |
|
|
2022
Q1 | $45.2M | Buy |
7,775,327
+1,570,740
| +25% | +$9.34M | ﹤0.01% | 1824 |
|
|
2021
Q4 | $46.5M | Buy |
6,204,587
+334,832
| +6% | +$2.91M | ﹤0.01% | 1853 |
|
|
2021
Q3 | $52.9M | Sell |
5,869,755
-124,411
| -2% | -$1.23M | ﹤0.01% | 1764 |
|
|
2021
Q2 | $71.8M | Sell |
5,994,166
-548,501
| -8% | -$6.21M | ﹤0.01% | 1570 |
|
|
2021
Q1 | $82M | Buy |
6,542,667
+165,610
| +3% | +$2.23M | ﹤0.01% | 1384 |
|
|
2020
Q4 | $99.5M | Sell |
6,377,057
-648,110
| -9% | -$7.59M | 0.01% | 1145 |
|
|
2020
Q3 | $66.4M | Buy |
7,025,167
+536,249
| +8% | +$5.8M | ﹤0.01% | 1244 |
|
|
2020
Q2 | $58.1M | Buy |
6,488,918
+1,641,150
| +34% | +$15.2M | ﹤0.01% | 1351 |
|
|
2020
Q1 | $30.9M | Buy |
4,847,768
+33,142
| +0.7% | +$246K | ﹤0.01% | 1560 |
|
|
2019
Q4 | $40.3M | Sell |
4,814,626
-204,450
| -4% | -$1.88M | ﹤0.01% | 1659 |
|
|
2019
Q3 | $45.4M | Sell |
5,019,076
-328,832
| -6% | -$3.69M | ﹤0.01% | 1511 |
|
|
2019
Q2 | $57.6M | Sell |
5,347,908
-504,733
| -9% | -$5.37M | ﹤0.01% | 1390 |
|
|
2019
Q1 | $55.8M | Sell |
5,852,641
-57,511
| -1% | -$587K | ﹤0.01% | 1379 |
|
|
2018
Q4 | $67.8M | Sell |
5,910,152
-602,475
| -9% | -$7.48M | 0.01% | 1155 |
|
|
2018
Q3 | $110M | Buy |
6,512,627
+431,983
| +7% | +$6.57M | 0.01% | 1006 |
|
|
2018
Q2 | $86.3M | Buy |
6,080,644
+1,543,693
| +34% | +$25.6M | 0.01% | 1135 |
|
|
2018
Q1 | $86.2M | Buy |
4,536,951
+557,358
| +14% | +$11.9M | 0.01% | 1092 |
|
|
2017
Q4 | $65.3M | Buy |
3,979,593
+1,088,783
| +38% | +$16.2M | 0.01% | 1264 |
|
|
2017
Q3 | $43.4M | Buy |
2,890,810
+1,022,525
| +55% | +$11.3M | ﹤0.01% | 1472 |
|
|
2017
Q2 | $16.4M | Buy |
1,868,285
+636,296
| +52% | +$4.08M | ﹤0.01% | 2125 |
|
|
2017
Q1 | $6.41M | Buy |
1,231,989
+45,420
| +4% | +$182K | ﹤0.01% | 2580 |
|
|
2016
Q4 | $3.61M | Sell |
1,186,569
-1,239,983
| -51% | -$4.52M | ﹤0.01% | 2854 |
|
|
2016
Q3 | $11.2M | Buy |
2,426,552
+519,612
| +27% | +$2.64M | ﹤0.01% | 2128 |
|
|
2016
Q2 | $11M | Sell |
1,906,940
-344,823
| -15% | -$2.2M | ﹤0.01% | 2166 |
|
|
2016
Q1 | $13.6M | Buy |
2,251,763
+397,097
| +21% | +$2.38M | ﹤0.01% | 1985 |
|
|
2015
Q4 | $16.9M | Sell |
1,854,666
-2,374,532
| -56% | -$18.3M | ﹤0.01% | 1833 |
|
|
2015
Q3 | $23.9M | Buy |
4,229,198
+828,213
| +24% | +$6.83M | ﹤0.01% | 1641 |
|
|
2015
Q2 | $37.7M | Buy |
3,400,985
+883,602
| +35% | +$11.4M | ﹤0.01% | 1434 |
|
|
2015
Q1 | $39.5M | Buy |
2,517,383
+190,274
| +8% | +$2.94M | ﹤0.01% | 1378 |
|
|
2014
Q4 | $35.4M | Sell |
2,327,109
-206,077
| -8% | -$2.5M | ﹤0.01% | 1407 |
|
|
2014
Q3 | $27.3M | Buy |
2,533,186
+412,836
| +19% | +$5.39M | ﹤0.01% | 1513 |
|
|
2014
Q2 | $32.4M | Buy |
2,120,350
+218,851
| +12% | +$3.15M | ﹤0.01% | 1472 |
|
|
2014
Q1 | $34.4M | Sell |
1,901,499
-370,113
| -16% | -$7.13M | ﹤0.01% | 1415 |
|
|
2013
Q4 | $31.6M | Buy |
2,271,612
+112,815
| +5% | +$1.3M | ﹤0.01% | 1456 |
|
|
2013
Q3 | $22.6M | Sell |
2,158,797
-561,229
| -21% | -$5.57M | ﹤0.01% | 1618 |
|
|
2013
Q2 | $21.2M | Buy |
+2,720,026
| New | +$23.7M | ﹤0.01% | 1599 |
|
Other funds holding SGMO
AC
VCM
VFT
State Street's SGMO Position: Q1 2026 in Review
State Street increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 25% in Q1 2026, buying an estimated $135K and bringing the position to 1,694,783 shares worth $418K. The position accounts for ﹤0.01% of the portfolio, ranked #3704.
State Street first reported a position in SGMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $110M in Q3 2018. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.
- State Street held 1,694,783 shares of SANGAMO THERAPEUTICS INC worth $418K as of Q1 2026.
- State Street bought 339,200 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $135K.
- SANGAMO THERAPEUTICS INC made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3704 holding.
- State Street first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 52 quarters since.
- State Street's SANGAMO THERAPEUTICS INC position peaked at $110M in Q3 2018.
- 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.